A Novel Coincidence: Essential Thrombocythemia with Facioscapulohumeral Muscular Dystrophy

A Novel Coincidence: Essential Thrombocythemia with Facioscapulohumeral Muscular Dystrophy

Bibliographic Details
Main Authors:	Ceren Hangül, Orhan Kemal Yücel, Aslı Toylu, Hilmi Uysal, Sibel Berker Karaüzüm
Format:	Article
Language:	English
Published:	Galenos Publishing House 2020-11-01
Series:	Turkish Journal of Hematology
Subjects:	essential thrombocythemia et facioscapulohumeral muscular dystrophy fshd jak2 p.v617f mutation
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-53367

Similar Items

Evaluation of Optical Genome Mapping in Clinical Genetic Testing of Facioscapulohumeral Muscular Dystrophy
by: Anja Kovanda, et al.
Published: (2023-11-01)

Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy
by: Victor Corasolla Carregari, et al.
Published: (2020-12-01)

RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy
by: Virginie Mariot, et al.
Published: (2021-12-01)

Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review
by: Tai-Heng Chen, et al.
Published: (2020-10-01)

Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy
by: Louise A Moyle, et al.
Published: (2016-11-01)

Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7
by: Christopher R S Banerji, et al.
Published: (2021-08-01)

On the Role of Delays to Diagnosis of Facioscapulohumeral Muscular Dystrophy
by: Elan Schonfeld, et al.
Published: (2022-09-01)

Quantitative proteomics reveals key roles for post-transcriptional gene regulation in the molecular pathology of facioscapulohumeral muscular dystrophy
by: Sujatha Jagannathan, et al.
Published: (2019-01-01)

Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials
by: Mehdi Ghasemi, et al.
Published: (2022-02-01)

Nutritional Status of Patients with Facioscapulohumeral Muscular Dystrophy
by: Sedda Amzali, et al.
Published: (2023-03-01)

The development of myasthenia gravis in a patient with facioscapulohumeral muscular dystrophy: case report and literature review
by: Feryal Nauman, et al.
Published: (2019-06-01)

Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral Dystrophy
by: Christopher R. Heier, et al.
Published: (2020-11-01)

ANT1 overexpression models: Some similarities with facioscapulohumeral muscular dystrophy
by: Sandrine Arbogast, et al.
Published: (2022-10-01)

Influence of <i>DUX4</i> Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments
by: Elisa Duranti, et al.
Published: (2023-05-01)

A feasibility study of noninvasive prenatal diagnosis in facioscapulohumeral muscular dystrophy type 1 in a Chinese family
by: Yayun Qin, et al.
Published: (2022-10-01)

Therapeutic Strategies Targeting DUX4 in FSHD
by: Laura Le Gall, et al.
Published: (2020-09-01)

Type 1 FSHD with 6–10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention
by: Emmanuelle Salort-Campana, et al.
Published: (2020-03-01)

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
by: İpek Yonal, et al.
Published: (2016-05-01)

p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy
by: Darko Bosnakovski, et al.
Published: (2017-10-01)

Artificial Intelligence for Evaluation of Retinal Vasculopathy in Facioscapulohumeral Dystrophy Using OCT Angiography: A Case Series
by: Martina Maceroni, et al.
Published: (2023-03-01)

Concomitant Essential Thrombocythemia and Mature B -Lymphoproliferative Disorder in a Patient
by: Ayesha Butt, et al.
Published: (2021-10-01)

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?
by: Romains Joubert, et al.
Published: (2020-12-01)

FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?
by: Charis L. Himeda, et al.
Published: (2022-05-01)

Facial paresis as the first sign in atypical facioscapulohumeral muscular dystrophy
by: Nneoma S. Wamkpah, et al.
Published: (2022-11-01)

Combined Lumbar-Sacral Plexus Block in Facioscapulohumeral Muscular Dystrophy for Hip Fracture Surgery: A Case Report
by: Mete Manici, et al.
Published: (2024-02-01)

Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies
by: José Luis García-Giménez, et al.
Published: (2022-12-01)

Molecular and Phenotypic Changes in FLExDUX4 Mice
by: Kelly Murphy, et al.
Published: (2023-06-01)

A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy
by: Qing Feng, et al.
Published: (2015-01-01)

Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients
by: Zehra Narlı Özdemir, et al.
Published: (2024-03-01)

Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy
by: Adam J. Bittel, et al.
Published: (2020-08-01)

Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease
by: Ceren HANGUL, et al.
Published: (2022-09-01)

Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study
by: Edyta Blaszczyk, et al.
Published: (2021-11-01)

An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy
by: Matthew V Cowley, et al.
Published: (2023-05-01)

Proximity ligation assay to detect DUX4 protein in FSHD1 muscle: a pilot study
by: Mary Lou Beermann, et al.
Published: (2022-05-01)

Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
by: Virginie Mariot, et al.
Published: (2022-07-01)

EYE PATHOLOGIES IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (CASE REPORT AND LITERARY ANALYSIS)
by: E. V. Denisova, et al.
Published: (2018-10-01)

Facioscapulohumeral dystrophy weakened sarcomeric contractility is mimicked in induced pluripotent stem cells‐derived innervated muscle fibres
by: Camille Laberthonnière, et al.
Published: (2022-02-01)

Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells
by: Christopher D. Sarsons, et al.
Published: (2023-09-01)

Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study
by: Elvira Ragozzino, et al.
Published: (2023-10-01)

Multimodal Imaging Findings in Retinopathy Associated with Facioscapulohumeral Muscular Dystrophy before and after Treatment with Intravitreal Aflibercept and Laser Photocoagulation
by: Hiroshi Shimizu, et al.
Published: (2022-07-01)